| PERIOD ENDING | 31-May-08 | 29-Feb-08 | 30-Nov-07 | 31-Aug-07 | | Total Revenue | 639,065 | 794,224 | 2,070,580 | 1,543,900 | | Cost of Revenue | 755,840 | 912,641 | 2,168,314 | 2,002,381 | | | Gross Profit | (116,775) | (118,417) | (97,734) | (458,481) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 120,178 | 128,757 | 229,922 | 198,277 | | Non Recurring | 24,570 |
-
|
-
| 107,926 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (261,523) | (247,174) | (327,656) | (764,684) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,522 | 13,032 | 9,754 | 8,614 | | Earnings Before Interest And Taxes | (255,330) | (267,872) | (398,953) | (772,730) | | Interest Expense |
-
|
-
|
-
| 12,990 | | Income Before Tax | (255,330) | (267,872) | (398,953) | (785,720) | | Income Tax Expense | 600 | 300 | 373,700 | (307,100) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (255,930) | (268,172) | (772,653) | (478,620) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 443,008 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (255,930) | (268,172) | (772,653) | (35,612) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($255,930) | ($268,172) | ($772,653) | ($35,612) |
|
1.47% Nasdaq 
0.03 (0.14%) 
Income Statement
